• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Genworth Financial Inc

    4/30/25 4:21:41 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    8-K
    GENWORTH FINANCIAL INC false 0001276520 0001276520 2025-04-30 2025-04-30
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    April 30, 2025

    Date of Report

    (Date of earliest event reported)

     

     

     

    LOGO

    GENWORTH FINANCIAL, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware
      001-32195
      80-0873306

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    11011 West Broad Street, Glen Allen, Virginia
      23060
    (Address of principal executive offices)   (Zip Code)

    (804) 281-6000

    (Registrant’s telephone number, including area code)

    N/A

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol

     

    Name of each exchange

    on which registered

    Common Stock, par value $.001 per share   GNW   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 2.02

    Results of Operations and Financial Condition.

    On April 30, 2025, Genworth Financial, Inc. (the “Company”) issued (1) a press release announcing its financial results for the quarter ended March 31, 2025, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, and (2) a financial supplement for the quarter ended March 31, 2025, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

    The information contained in this Current Report on Form 8-K (including the exhibits) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the company under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

     

    Item 9.01

    Financial Statements and Exhibits.

    The following materials are furnished as exhibits to this Current Report on Form 8-K:

     

    Exhibit
    Number

      

    Description of Exhibit

    99.1    Press Release dated April 30, 2025
    99.2    Financial Supplement for the quarter ended March 31, 2025
    104    Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document)


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        GENWORTH FINANCIAL, INC.
    Date: April 30, 2025     By:  

    /s/ Darren W. Woodell

          Darren W. Woodell
          Vice President and Controller
          (Principal Accounting Officer)
    Get the next $GNW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GNW
    Financials

    Live finance-specific insights

    See more
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Schedules Earnings Conference Call for May 1

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on April 30, 2025. A conference call will be held on May 1, 2025, at 10:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 1 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #3161071. To participate in the call by

      4/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces Fourth Quarter 2024 Results

      Strategic Highlights Expanded the CareScout Quality Network to all 50 states, covering over 86% of the aged 65-plus census population in the United States Continued progress on the LTC1 multi-year rate action plan with $40M of gross incremental premium approvals; approximately $31.2B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Executed $51M in share repurchases in the quarter at an average price of $7.32 per share; $186M executed in 2024 at an average price of $6.52 per share; $565M in share repurchases program-to-date through February 14th at an average price of $5.69 per share Repurchased $31M in principal of holding company debt at a discount

      2/18/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance

    $GNW
    SEC Filings

    See more
    • SEC Form 8-K filed by Genworth Financial Inc

      8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

      5/22/25 4:16:10 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SCHEDULE 13G filed by Genworth Financial Inc

      SCHEDULE 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      5/13/25 4:01:16 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form 10-Q filed by Genworth Financial Inc

      10-Q - GENWORTH FINANCIAL INC (0001276520) (Filer)

      5/2/25 6:31:11 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Genworth Financial Inc

      SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      10/25/24 3:16:06 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

      SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

      2/13/24 5:06:12 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SC 13G filed by Genworth Financial Inc

      SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      2/9/24 9:59:00 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $GNW
    Leadership Updates

    Live Leadership Updates

    See more

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Director Van Wyk Steven C. was granted 45,576 shares (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:24:22 PM ET
      $GNW
      Life Insurance
      Finance
    • Director Smith Ramsey D. was granted 23,681 shares, increasing direct ownership by 47% to 74,391 units (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:24:07 PM ET
      $GNW
      Life Insurance
      Finance
    • Director Sarsynski Elaine A was granted 41,622 shares, increasing direct ownership by 46% to 132,899 units (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:23:47 PM ET
      $GNW
      Life Insurance
      Finance
    • CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

      CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

      2/13/24 8:30:00 AM ET
      $GNW
      Life Insurance
      Finance
    • Genworth And Oceanwide Provide Transaction Update; Genworth To Focus on Contingency Plan

      RICHMOND, Va., Jan. 4, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) (Genworth, the Company) and China Oceanwide Holdings Group Co., Ltd. (Oceanwide) today provided an update on their pending transaction. Given uncertainty around the completion and timing of the remaining steps required to close the transaction, Genworth and Oceanwide have not extended the current December 31, 2020 "end date" under the merger agreement. Oceanwide has indicated that the factors contributing to the delay since the parties agreed to their most recent extension of the merger agreement on November 30, 2020 were: (a) the finalization of the Hony Capital financing terms; and (b) the COVID-19 pandemi

      1/4/21 7:00:00 AM ET
      $GNW
      Life Insurance
      Finance
    • Genworth Financial Announces Results of Annual Meeting

      Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th

      5/22/25 1:32:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Schedules Earnings Conference Call for May 1

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on April 30, 2025. A conference call will be held on May 1, 2025, at 10:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 1 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #3161071. To participate in the call by

      4/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance